# PUL-042 Treatment in Patients With Parainfluenza Virus (PIV), Human Metapneumovirus (hMPV) or Respiratory Syncytial Virus (RSV)

> clinical trial · VERIFIED · 2026-08-04

Status: RECRUITING · Sponsor: Pulmotect, Inc. · Condition: Hematologic Malignancies

- Company: Pulmotect, Inc.
- Sector: biotech
- Primary source: https://clinicaltrials.gov/study/NCT06665100

---
Source: MedFuel Intel news monitor. Verification tier: VERIFIED. Informational only, not investment advice. Corrections: media@medfuelinc.com.